Company Analysis - Wockhardt Limited

Publication Date	December 2007
Publisher	RNCOS
Product Type	Report
Pages	30
ISBN Number	not applicable
Product Code	RCS00358

Price

£150.00
approximately: $300 | €188

PDF

PRINT £200 ($400 | €250)

CD-ROM £200 ($400 | €250)

Order above formats by FAX

Summary

Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.

The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.

The report is based on extensive research using data available from credible publications, trade journals, industry associations and the company sources.

Report Highlights

Provides a comprehensive version of the company's performance
Offers key financial data, ratio and SWOT analysis
Tracks major M&A trends and developments
Business Profile, SWOT analysis and financial information on top five competitors
View on the company by our analysts
Supplemented with graphs and tabular information wherever necessary

Content

1. Company Overview
- 1.1 History
- 1.2 Business Overview
- 1.3 Organizational Structure
- 1.4 Ticker Codes at various Stock Exchange Listings
- 1.5 Major Mergers & Acquisitions
- 1.6 Management Profile
2. Product & Services
- 2.1 Product & Services - An Overview
- 2.2 Revenue & Income Summary by Geographical Distribution
- 2.3 Revenue & Income Summary by Business Segment
3. Financial Information for the Fiscal Year
- 3.1 Financial Summary for the Fiscal Year
- 3.2 Breakup of Revenue & Sales Trends
- 3.3 Ratio & Market Indicators
- 3.4 Earning & Income Estimates
4. SWOT Analysis
- 4.1 Strength
- 4.2 Weaknesses
- 4.3 Opportunity
- 4.4 Threats
5. Top Competitors (Key Financials & SWOT Analysis)
- 5.1 Aurobindo Pharma Limited
- 5.2 Cipla Limited
- 5.3 Glaxo Smithkline Pharmaceuticals Limited
- 5.4 Dr. Reddy's Laboratories Limited
- 5.5 Ranbaxy Laboratories Limited
6. Analyst View
List of Figures:
- Figure 2 1: Wockhardt Limited - Revenue by Geographical Distribution (in Million Rs), 2006
List of Tables:
- Table 1-1: Wockhardt Limited - Ticker Codes at various Stock Exchanges
- Table 1-2: Wockhardt Limited - Major Mergers & Acquisitions (2000 to 2007)
- Table 1-3: Wockhardt Limited - Key Management People
- Table 3-1: Wockhardt Limited - Financials Overview (in Million Rs), 2006
- Table 3-2: Wockhardt Limited - Breakup of Revenue & Sales (in Million Rs), 2004-2006
- Table 3-3: Wockhardt Limited - Key Financial Ratios (2004-2006)
- Table 3-4: Wockhardt Limited - Earning & Income Estimates (in Million Rs), 2004-2006
- Table 5-1: Aurobindo Pharma Limited - Key Financials (in Million Rs), March 2005 to March 2007
- Table 5-2: Aurobindo Pharma Limited - SWOT Analysis
- Table 5-3: Cipla Limited - Key Financials (in Rs Crore), 2005-06 & 2006-07
- Table 5-4: Cipla Limited - SWOT Analysis
- Table 5-5: Glaxo Smithkline Pharmaceuticals Limited - Key Financials (in Rs Lakh), 2005 & 2006
- Table 5-6: Glaxo Smithkline Pharmaceuticals Limited - SWOT Analysis
- Table 5-7: Dr. Reddy's Laboratories Limited - Key Financials (in Million Rs), March 2005 to March 2007
- Table 5-8: Dr. Reddy's Laboratories Limited - SWOT Analysis
- Table 5-9: Ranbaxy Laboratories Limited - Key Financials (in Million Rs), 2004-2006
- Table 5-10: Ranbaxy Laboratories Limited - SWOT Analysis